Skip to main content

Advertisement

Table 4 STD Productivity Loss and Indirect Costs in Propensity Score Matched Cohorts with STD Eligibility

From: Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures

Measure Patients with STD Eligibility
With CVERP Without CVERP p-value
N = 21,006 N = 21,006  
n/mean %/SD n/mean %/SD  
During the 1st month of follow-up:      
Patients reporting STD (n, %) 8,764 41.7 1,011 4.8 <.001
Monthly hours lost due to STD (mean, SD) 57.7 74.6 6.0 29.7 <.001
Indirect costs associated with STD (mean, SD) $996 $1,309 $102 $506 <.001
Patients with ≥ 1 year of follow-up (n, %) 12,632 60.1 13,527 64.4  
During the 1st year of follow-up:      
Patients reporting STD (n, %) 5,890 46.6 1,406 10.4 <.001
Monthly hours lost due to STD (mean, SD) 16.3 30.8 3.6 16.7 <.001
Indirect costs associated with STD (mean, SD) $281 $529 $60 $278 <.001
Patients with ≥ 2 years of follow-up (n, %) 7,196 34.3 8,038 38.3  
During the 2nd year of follow-up:      
Patients reporting STD (n, %) 1,031 14.3 734 9.1 <.001
Monthly hours lost due to STD (mean, SD) 4.7 18.0 2.7 13.3 <.001
Indirect costs associated with STD (mean, SD) $79 $308 $45 $219 <.001
Patients with ≥ 3 years of follow-up (n, %) 3,984 19.0 4,635 22.1  
During the 3rd year of follow-up:      
Patients reporting STD (n, %) 536 13.5 364 7.9 <.001
Monthly hours lost due to STD (mean, SD) 4.4 17.9 2.1 10.8 <.001
Indirect costs associated with STD (mean, SD) $73 $298 $34 $177 <.001
  1. CVERP: cardiovascular events and related clinical procedures; SD: standard deviation; STD: short-term disability